Shelly I agree , I liked very much today CC, FDA

Shelly I agree , I liked very much today CC,
FDA never , ever had a question about efficacy or safety of our Leronlimab ,

And we may not like all , but this is the most important always with new drugs to be approve or not ...


Just IMO.